Skip to main content

Table 2 Univariate analysis of correlation between RHI and clinical indicators

From: Endothelial function measured by peripheral arterial tonometry in patients with chronic myeloid leukemia on tyrosine kinase inhibitor therapy: a pilot study

Variables

r

P-value

Age, yrs

0.139

0.464

Male sex

-0.222

0.239

BMI, kg/m2

0.013

0.945

Systolic BP, mmHg

-0.197

0.297

Diastolic BP, mmHg

-0.393

0.032

Current smoker

-0.36

0.051

Hemoglobin, g/dL

-0.356

0.053

Serum creatinine, mg/dL

-0.141

0.458

Serum uric acid, mg/dL

-0.399

0.029

Triglycerides, mg/dL

0.070

0.713

HDL-C, mg/dL

-0.163

0.390

LDL-C, mg/dL

0.025

0.894

HbA1c, %

-0.118

0.534

  1. BMI Body mass index, BP Blood pressure, TKI Tyrosine kinase inhibitor, CCB Calcium channel blocker, ACE-I/ARB Angiotensin converting enzyme inhibitors/angiotensin II receptor blockers, WBC White blood cell, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol
Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us